Screener
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Titan International in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Titan International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:18 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899751-26-000041
| Line item | Three months ended / March 31, 2026 | 2025 |
|---|---|---|
| Cost of sales | 433,624 | 422,064 |
| Gross profit | 71,449 | 68,644 |
| Selling, general, and administrative expenses | 52,398 | 49,855 |
| Research and development expenses | 5,284 | 4,544 |
| Royalty expense | 2,410 | 2,446 |
| Restructuring and impairment expenses | 25,142 | — |
| (Loss) income from operations | (13,785) | 11,799 |
| Interest expense | (9,887) | (9,535) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Titan International's R&D?
- Titan International (TWI) reported R&D of $5.28M in Q1 2026.
- How has Titan International's R&D changed year-over-year?
- Titan International's R&D increased by 16.3% year-over-year, from $4.54M to $5.28M.
- What is the long-term trend for Titan International's R&D?
- Over 4 years (2021 to 2025), Titan International's R&D has grown at a 16.0% compound annual growth rate (CAGR), from $10.1M to $18.32M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Titan International's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude